Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
angiotensin-converting enzyme, inhibitors
anterior cerebral artery, occlusion of
blindness
border zone infarct
cardiac surgery, neurologic complications with
carotid artery disease
carotid artery occlusion, intracranial
carotid artery stenosis
CAT scan
CAT scan, abnormal
CAT scan, angiography
CAT scan, angiography, false negative
CAT scan, cerebrovascular disease
CAT scan, early changes in CVA
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, false negative
CAT scan, gyral swelling
CAT scan, hypoattenuation
CAT scan, mismatch between cerebral blood volume/flow
CAT scan, mismatch between perfusion/diffusion
CAT scan, perfusion
CAT scan, xenon-enhanced
cerebral blood flow
cerebral blood volume
cerebral edema
cerebral edema, cytotoxic
cerebral edema, vasogenic
cerebral embolism
cerebral embolism, mechanical extraction
cerebral infarction
cerebral ischemia
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, arterial occlusion, absent
cerebrovascular accident, arterial occlusion, location
cerebrovascular accident, awakening with
cerebrovascular accident, classification
cerebrovascular accident, mimics
cerebrovascular accident, multiple
cerebrovascular accident, pathophysiology
cerebrovascular accident, prevention of
cerebrovascular accident, prognosis in
cerebrovascular accident, severity
cerebrovascular accident, spontaneous improvement after
cerebrovascular accident, surgical treatment of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, time of onset
cerebrovascular accident, time of presentation
cerebrovascular accident, time to treatment
cerebrovascular accident, unknown time of onset
cerebrovascular accident, vascular territory involved
cerebrovascular accident, volume
cerebrovascular accident, work up for
clinical mismatch
clot retrieval
collateral circulation
complications
controversies in neurology
cost effectiveness
DAWN stroke trial
DEFUSE study
desmoteplase
eclampsia
eclampsia, postpartum
efficacy
emergencies, neurologic
emergency room, treatment of stroke
emergent neuroimaging
endovascular therapy
endovascular therapy, selection criteria
endovascular therapy, time window
EPITHET trial
ethics in neurology
evidence-based research
EXTEND trial
false negative
false positive
fibrinolytic agents
fibrinolytic agents, complications
fibrinolytic agents, contraindications
fibrinolytic agents, intra-arterial local infusion
fibrinolytic therapy, selection criteria
fibrinolytic therapy, timing of administration
headache
hemiparesis
HMGcoA reductase inhibitors
hyperintense vessel sign
hyperperfusion syndrome
hypertension
iatrogenic neurologic disorders
infarct core
internet
interobserver agreement
intracerebral hemorrhage
ischemic core
ischemic penumbra
magnetoencephalography
MERCI trial
middle cerebral artery territory infarction
middle cerebral artery territory infarction, malignant
middle cerebral artery, occlusion of
mimics
misdiagnosis
MRI
MRI, abnormal
MRI, ADC maps
MRI, angiography
MRI, CAT scan compared to
MRI, cerebrovascular disease
MRI, diffusion weighted
MRI, disappearing lesion on
MRI, early changes in CVA
MRI, FLAIR
MRI, FLAIR, hyperintense vessels
MRI, functional
MRI, mismatch between DWI/FLAIR
MRI, mismatch between perfusion/diffusion
MRI, perfusion
MRI, serial
MRI, volumetry
MRS
multimodal neuroimaging
N-acetyl-L-aspartic acid
neurologic disease, diagnoses of
neurologic examination, focal
neuroprotective agents
neuroradiology, interventional
NIH stroke scale
NMDA antagonists
occipital lobe, lesion of
optic neuropathy
pitfalls
placebo
platelet inhibiting drugs
posterior leukoencephalopathy syndrome
postpartum
postpartum cortical blindness
practice guidelines
pre-eclampsia
pregnancy, neurologic complications in
prevention of neurologic disorders
prognosis
Rankin score
RAPID CT perfusion maps
recanalization, arterial
reperfusion
revascularization, surgical
reversible ischemia
reversible ischemic neurologic deficit
reversible neurologic disorder
review article
safety
sedation
statin therapy
stroke disability scale
stroke, progression of
SWIFT PRIME Trials
symmetric brain lesions
T lesion of MCA-ICA
telemedicine
teleradiology
thrombectomy
thrombolysis, mechanical
tick paralysis
time is brain
tissue plasminogen activator, intravenous
transient neurologic deficit
treatment of neurologic disorder
Trevo retriever
vasospasm, cerebral
watershed infarcts
Showing articles 0 to 50 of 15231 Next >>

Intravenous Alteplase for Stroke with Unknown Time of Onset Guided by Advanced Imaging:Systematic Review and Meta-Analysis of Individual Patient Data
Lancet 396:1574-1585, Thomalla,G.,et al, 2020

Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke
NEJM 380:1795-1803,1865, Ma, H.,et al, 2019

Penumbra Detection in Acute Stroke with Perfusion Magnetic Resonance Imaging: Validation with 15 O-Positron Emission Tomography
Ann Neurol 85:875-886, Zaro-Weber, O.,et al, 2019

Extending Thrombolysis to 4.5-9 h and Wake-Up Stroke Using Perfusion Imaging: A Systematic Review and Meta-Analysis of Individual Patient Data
Lancet 394:139-147,97, Campbell, B.C.V.,et al, 2019

Automated CT Perfusion Imaging for Acute Ischemic Stroke
Neurol 93:888-898, Vagal, A.,et al, 2019

No-Cutoff Large Vessel Occlusion Stroke
Neurol 93;1014-1015, Atchaneeyasakul, K.,et al, 2019

Use of Imaging to Select Patients for Late Window Endovascular Therapy
Stroke 49:2256-2260, Albers, G.W., 2018

Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
NEJM 378:11-22,81, Nogueira, R.G.,et al, 2018

Hyperintense Vessels on FLAIR: Hemodynamic Correlates and Response to Thrombolysis
AJNR 36:1426-1430, Kufner, A.,et al, 2015

Treatment Concepts for Wake-Up Stroke and Stroke with Unknown Time of Symptom Onset
Stroke 46:2707-2713, Thomalla, G. & Gerloff, C., 2015

Endovascular Treatment for Acute Ischemic Stroke-Still Unproven
NEJM 368:952-955, Chimowitz,M., 2013

A Trial of Imaging Selection and Endovascular Treatment for Ischemic Stroke
NEJM 368:914-923,952, Kidwell, C.S.,et al, 2013

Advanced Brain Imaging Studies Should Be Performed in Patients With Suspected Stroke Presenting Within 4.5 Hours of Symptom Onset
Stroke 42-2666-2667,2670, Parsons, M.W., 2011

Advanced Brain Imaging Studies Should Not Be Performed in Patients With Suspected Stroke Presenting Within 4.5 Hours of Symptom Onset
Stroke 42:2668-2669,2670, Lyden, P.D., 2011

Endovascular Treatment of Acute Ischemic Stroke May Be Safely Performed With No Time Window Limit in Appropriately Selected Patients
Stroke 41:1996-2000, Abou-Chebl,A.,et al, 2010

MR Mismatch Is Useful for Patient Selection for Thrombolysis: Yes
Stroke 40:2906-2907,2910, Fiebach,J.B. &Schellinger,P.D., 2009

Recommendations for Imaging of Acute Ischemic Stroke: A Scientific Statement From the American Heart Association
Stroke 40:3646-3678, Latchaw,R.,et al, 2009

Use of MRI to Estimate the Therapeutic Window in Acute Stroke: Is Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch an EPITHET for Salvageable Ischemic Brain Tissue?
Stroke 40:333-335, Toth,G. &Albers,G.W., 2009

Distal Hyperintense Vessels on FLAIR: An MRI Marker for Collateral Circulation in Acute Stroke?
Neurol 72:1134-1139, Lee,K.Y.,et al, 2009

The Ethics of Thrombolytic Trials Beyond 3 (or 4.5) Hours: Randomized Controlled Trials Are Required to Change Clinical Practice
Stroke 40:1545, Donnan,G.A. &Davis,S.M., 2009

Cost-Effectiveness of Patient Selection Using Penumbral-Based MRI for Intravenous Thrombolysis
Stroke 40:1710-1720, Earnshaw,S.R.,et al, 2009

Rapid Assessment of Perfusion-Diffusion Mismatch
Stroke 39:75-81, Butcher,K.,et al, 2008

MR Imaging-Based Decision in Thrombolytic Therapy for Stroke on Awakening: Report of 2 Cases
AJRN 29:1314-1316, Iosif,C.,et al., 2008

Quantitative Assessment of Core/Penumbra Mismatch in Acute Stroke: CT and MR Perfusion Imaging Are Strongly Correlated When Sufficient Brain Volume Is Imaged
Stroke 39:2986-2992, Schaefer,P.W.,et al, 2008

Identification of the Penumbra and Infarct Core on Hyperacute Noncontrast and Perfusion CT
Neurol 68:730-736,717, Parsons,M.W.,et al, 2007

Comparison of CT Perfusion and Angiography and MRI in Selecting Stroke Patients for Acute Treatment
Neurol 68:694-697, Wintermark,M.,et al, 2007

Magnetic Resonance Perfusion Diffusion Mismatch and Thrombolysis in Acute Ischaemic Stroke: A Systematic Review of the Evidence to Date
JNNP 78:485-491,443, Kane,I.,et al, 2007

Evaluation of the Clinical-Diffusion and Perfusion-Diffusion Mismatch Models in DEFUSE
Stroke 38:1826-1830,1718, Lansberg,M.G.,et al, 2007

CT-NIHSS Mismatch Does Not Correlate With MRI Diffusion-Perfusion Mismatch
Stroke 38:2079-2084,2028, Mess,S.R.,et al, 2007

Systematic Comparison of Perfusion-CT and CT-Angiography in Acute Stroke Patients
Ann Neurol 61:533-543,501, Tan,J.C.,et al, 2007

Can the Ischemic Penumbra Be Identified on Noncontrast CT of Acute Stroke?
Storke 38:2485-2490, Muir,K.W.,et al, 2007

First-Pass Quantitiative CT Perfusion Identifies Thresholds for Salvageable Penumbra in Acute Stroke Patients Treated with Intra-arterial Therapy
AJNR 27:20-25, Schaefer,P.W.,et al, 2006

Imaging-Guided Acute Ischemic Stroke Therapy: From "Time is Brain" to "Physiology is Brain"
AJNR 27:728-735, Gonzalez,R.G., 2006

Antiplatelets, ACE Inhibitors, and Statins Combination Reduces Stroke Severity and Tissue At Risk
Neurol 66:1153-1158, Kumar,S.,et al, 2006

Cerebral Blood Flow Threshold of Ischemic Penumbra and Infarct Core in Acute Ischemic Stroke. A Systematic Review.
Stroke 37:1334-1339, Bandera,E.,et al, 2006

Is Penumbral Imaging Useful for Extending the Treatment Window for Intravenous Tissue Plasminogen Activator?
Ann Neurol 60:499-501, Fisher,M., 2006

Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1099-1100, 1100, Zivin,J.A., 2005

Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now Be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1098-1099,1100, Schellinger,P.D. &Fiebach,J.B., 2005

Magnetic Resonance Imaging Criteria for Thrombolysis in Acute Cerebral Infarct
Stroke 36:388-397, Hjort, N., et al, 2005

Perfusion Computed Tomography: Prediction of Final Infarct Extent and Stroke Outcome
Ann Neurol 58:672-679,661, Parsons,M.W.,et al, 2005

The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase
Stroke 36:66-73, Hacke,W.,et al, 2005

The Clinical-DWI Mismatch
Neurol 62:2187-2192, Davalos,A.,et al, 2004

Are There Time-Dependent Differences in Diffusion and Perfusion Within the First 6 Hours After Stroke Onset?
Stroke 35:2099, Fiehler,J.,et al, 2004

A Case of Reversible Postpartum Cytotoxic Edema in Preeclampsia
JNeuroSci 221:83-87, Na,S.-J.,et al, 2004

Imaging-Based Decision Making in Thrombolytic Therapy for Ischemic Stroke
Stroke 34:575-583, Schellinger,P.D.,et al, 2003

Assessing Tissue Viability with MR Diffusion and Perfusion Imaging
AJNR 24:436-443, Schaefer,P.W.,et al, 2003

Differences in the Diagnostic Accuracy of Acute Stroke Clinical Subtypes Defined by Multimodal Magnetic Resonance Imaging
JNNP 74:886-888,840, Allder,S.J.,et al, 2003

Perfusion-Weighted Magnetic Resonance Imaging Thresholds Identifying Core, Irreversibly Infarcted Tissue
Stroke 34:1425-1430, Shih,L.C.,et al, 2003

Reliability of Assessing Percentage of Diffusion-Perfusion Mismatch
Stroke 34:1681-1685, Coutts,S.B.,et al, 2003



Showing articles 0 to 50 of 15231 Next >>